We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Allergan Resubmits sBLA for Botox to Treat Lower Limb Spasticity
Allergan Resubmits sBLA for Botox to Treat Lower Limb Spasticity
Allergan has resubmitted its sBLA for Botox, providing the FDA with additional study data on the effects of the injectable drug on lower limb spasticity.